Overt bone metastasis and bone marrow micrometastasis of early gastric cancer.
Recently we encountered two cases of early gastric cancer (EGC) with bone metastasis after surgery. As they were not accompanied by overt liver, lung, or peritoneal metastasis, we examined the clinical significance of bone metastasis in EGC and its mechanisms by a review of the literature. We found only 10 cases of EGC complicated with overt bone metastasis in the English literature, so we also examined the Japanese reports of such cases. The main histologic type of cases of bone metastasis from EGC was the diffuse type, and there were long intervals between surgery and overt bone metastasis. One reason for such long intervals may have been the tumor dormancy. Two types of dormancy, dynamic and static, and two types of postoperative overt metastases, that of micrometastatic origin (normograde metastatic process) and that of bone marrow origin (retrograde metastatic process), were considered. We speculated that there may be specific routes by which the cancer cells infiltrate the bone marrow directly from EGC or lymph node metastasis. The procedures for diagnosing bone micrometastasis using monoclonal antibodies have recently been improved, but their accuracy rates are still not universally accepted. New, more reliable examinations are required to improve the survival rates of EGC.
Fourth Department of Surgery, Tokyo Medical University Ibaraki Medical Center, 3-20-1 Chuo, Ami, Inashiki, Ibaraki, Japan.
Hideyuki
H
Ubukata
Gyou
G
Motohashi
Takanobu
T
Tabuchi
Hiroyuki
H
Nagata
Satoru
S
Konishi
Takafumi
T
Tabuchi
D019046:Bone Marrow Neoplasms / Q000556:secondary*; D001859:Bone Neoplasms / Q000556:secondary*; D006801:Humans; D013274:Stomach Neoplasms / Q000473:pathology*
Gastric Cancer. 2002;5(1):1-5
12021853
Radiology. 2005 Nov;237(2):627-34
16244271
Surg Today. 1998;28(7):753-7
9697271
Med Oncol. 1999 Sep;16(3):154-65
10523795
Clin Nucl Med. 1995 Apr;20(4):310-4
7788986
Surg Clin North Am. 2000 Dec;80(6):1799-809
11140874
Arch Surg. 1992 Nov;127(11):1303-8
1444791
Virchows Arch. 2001 Aug;439(2):109-17
11561750
J Hematother. 1996 Aug;5(4):359-67
8877711
Eur J Cancer Care (Engl). 2010 Jul;19(4):554-7
19709172
Jpn J Clin Oncol. 1996 Dec;26(6):472-5
9001355
Semin Nucl Med. 1976 Jan;6(1):19-31
1108208
J Pathol. 1986 Nov;150(3):195-203
3806280
Surg Today. 1997;27(4):334-6
9086550
World J Gastroenterol. 2005 Sep 28;11(36):5587-91
16237749
Clin Cancer Res. 1998 Sep;4(9):2129-34
9748130
Br J Cancer. 2007 Jun 4;96(11):1723-8
17486129
Langenbecks Arch Surg. 2004 Apr;389(2):69-74
14985987
J Surg Oncol. 1990 Mar;43(3):181-8
2179631
Oncology. 1978;35(3):114-26
673317
Gastroenterology. 2005 May;128(6):1567-78
15887152
Jpn J Thorac Cardiovasc Surg. 2002 Mar;50(3):93-103
11968725
Jpn J Surg. 1983 May;13(3):173-6
6632389
Tumori. 2001 May-Jun;87(3):191-5
11504376
Nat Med. 1995 Feb;1(2):149-53
7585012
J Natl Cancer Inst. 1994 Jan 5;86(1):45-8
8271282
J Am Coll Surg. 2003 Jan;196(1):68-74
12517553
Nucl Med Commun. 2008 Feb;29(2):137-43
18094635
Clin Cancer Res. 2008 May 1;14(9):2609-16
18451223
J Clin Oncol. 1990 May;8(5):831-7
1692090
Surg Today. 2009;39(12):1026-31
19997796
Ups J Med Sci. 2004;109(1):49-56
15124953
Acta Gastroenterol Belg. 2007 Apr-Jun;70(2):231-4
17715641
Proc Natl Acad Sci U S A. 1987 Dec;84(23):8672-6
2446326
Surg Today. 1997;27(6):563-6
9306553
Jpn J Clin Oncol. 1986 Dec;16(4):325-34
3025477
Eur J Cancer. 1991;27(11):1461-5
1720636
Eur J Surg Oncol. 2003 Jun;29(5):450-4
12798750
Gastric Cancer. 2010 Mar;13(1):30-5
20373073
Tumori. 1995 Jan-Feb;81(1):74-6
7754548
Ann Nucl Med. 2005 Feb;19(1):51-4
15770974
J Clin Oncol. 1996 Jun;14(6):1810-7
8656249
Cancer. 2000 Jul 15;89(2):255-61
10918153
Hepatogastroenterology. 2002 Nov-Dec;49(48):1751-4
12397785